National
Right-wing media watchdog project launched
Equality Matters created by gay ex-conservative David Brock
Former Clinton administration official Richard Socarides will head the newly created Equality Matters. (Photo courtesy Equality Matters)
Gay former conservative strategist and author David Brock, who changed sides in 2002 to become a champion of LGBT equality and progressive causes, announced the founding this week of a new initiative aimed at exposing “right-wing bigotry and homophobia wherever we find it.”
Brock said the new entity, Equality Matters, would be an arm of the progressive-leaning media watchdog group he founded in 2004 called Media Matters.
A statement released Monday says New York gay attorney and former Clinton administration official Richard Socarides would serve as president of Equality Matters. Lesbian journalist and Washington correspondent for The Advocate, Kerry Eleveld, was named editor of the project’s website, EqualityMatters.org, which organizers say will provide “news, opinion, and messaging” on LGBT-related issues in the media.
“Despite huge progress in gay rights in recent years, exemplified by the historic vote [on Dec. 18] finally striking down the ban on gay men and women from serving in the military, we are now living through a period of ferocious fundamentalism in the Republican Party and the conservative movement,” Brock said.
“Traditional conservatives and the Tea Party movement are united only in their contempt for equal rights for all Americans and a desire to return America to a 19th century idyll,” he said. “Equality Matters will not allow these latter-day ‘clerics’ to gain serious recognition by the media nor influence the policies that affect the lives of every American.”
A source familiar with Media Matters said the group and an affiliated entity, Media Matters Action network, raised about $23 million in 2010 in cash contributions and “long term commitments for 2011 and 2012.”
The New York Times reported that much of Media Matters’ funding comes from large contributions by wealthy liberal donors, including gay philanthropists.
The Blade source, who spoke on condition of not being identified, said the two entities yielded between $13 million and $14 in revenue this year. The 2010 figure disclosed by the source represents a significant boost in Media Matters’ revenue of $6.7 million in 2009 and $8.09 million raised in 2008, according to reports the group filed with the IRS in 2008 and 2009.
Socarides told the Blade Tuesday that Equality Matters would not have a separate budget and instead would operate under the Media Matters budget. He said Equality Matters, which would be based in the same offices as Media Matters at 455 Massachusetts Ave., N.W., would operate initially with a six-person staff, including him and Eleveld.
“We will draw on the Media Matters staff extensively,” he said. “And there are just under 100 people who work there. So we’ll have six people dedicated to just this and then parts of 95 others.”
According to Socarides, Equality Matters will not be involved in direct lobbying and won’t make campaign contributions – unlike existing LGBT groups like the Human Rights Campaign and the National Gay & Lesbian Task Force.
“Much like Media Matters already does on a broad range of issues, we will do news and information media monitoring,” he said. “And we’ll be a rapid response to any homophobic misinformation in the media or in political discourse. So part of our mission is to respond rapidly with smart and accurate information when the right wing – be it in media or politics – puts out misinformation.”
At least two activists involved with national LGBT groups said the launching of Equality Matters would likely trigger speculation among LGBT movement insiders about whether Brock and Socarides were seeking to step into the realm of other national LGBT groups that came under some criticism in the past year.
Expectations were high in January 2009 for significant progress on LGBT-related legislation as President Obama entered the White House and Democrats were in control of Congress, the two activists said. Although Congress passed an important hate crimes law last year with protections for LGBT people and last week repealed “Don’t Ask, Don’t Tell,” all other important bills remain stalled in committee. Among them is the Employment Non-Discrimination Act, or ENDA, which calls for banning employment discrimination based on sexual orientation and gender identity.
“The feeling among some of us is the established groups could have done more and could have put more pressure on the Democrats to do more,” said one of the activists.
But others, including gay U.S. Rep. Barney Frank (D-Mass.), considered one of the leading advocates for LGBT rights in Congress, have said there were not enough LGBT-supportive votes in Congress to advance the other bills. Frank has said it is up to LGBT advocates to do the lobbying and advocacy work in the sections of the country, especially the so-called “red states,” where members of Congress oppose LGBT equality and won’t vote for pro-gay bills.
Socarides said he sees Equality Matters as a new force that will work with the existing groups, including the Human Rights Campaign and Gay & Lesbian Alliance Against Defamation (GLAAD), which also specializes in media-related initiatives.
One gay activist, who spoke on condition of anonymity, questioned whether Equality Matters would be replicating the work of existing groups.
“Media Matters is fantastic at pushing back at conservative disinformation, and if they’re ramping up that function in the gay space, God bless,” the activist said. “But if they’re doing policy advocacy, plenty of people with vastly more substantive experience than Socarides are doing that pretty well, as the passage of DADT suggests. It’s not clear this isn’t a completely redundant vanity project, but I guess we’ll see.”
GLAAD, which has a budget of $7.95 million and a 48-member staff located in New York and Los Angeles, focuses on the positive portrayal of LGBT people in the media and in entertainment, according to its president, Jarrett Barrios.
“GLAAD fights defamation in the media from major outlets to small markets around the country,” Barrios said. “Some of GLAAD’s most visible work is in Hollywood, but much of our work is with journalists and news organizations to ensure accurate and responsible coverage of LGBT peoples’ lives and the issues that affect them.”
He said that unlike Equality Matters’ stated objective, GLAAD steers clear of addressing specific political and policy-making issues.
“I think our effort will be complimentary rather than overlapping with GLAAD,” said Socarides. “And in fact one of our core missions at Media Matters and at Equality Matters is to help other progressive and LGBT rights organizations fulfill their own missions.”
Now that “Don’t Ask, Don’t Tell” has been addressed legislatively, Socarides said Equality Matters plans to devote much of its resources to promoting same-sex marriage equality, both on the national and state level. He said the group would jump into the media fray as ballot measures seeking to ban same-sex marriage surface in the states.
He said Equality Matters would also push to advance legislation stalled in Congress to overturn the Defense of Marriage Act, which defines marriage under federal law as a union only between a man and a woman and bars all federal programs – including Social Security benefits – for same-sex married couples.
“Despite our best efforts over the years to stiffen the spines of progressives in the face of unrelenting smears from the Republican attack machine, fearful progressives continue to cede the political field to right-wingers who are waging war against core American values,” Brock said in a statement. “We need to do more. Our new communication war room for gay equality, Equality Matters, will expose right-wing bigotry and homophobia wherever we find it, show that the real political vulnerability on these issues belongs to the GOP, provide desperately needed ballast in the media, and trigger progressive passion – so that our political leaders act on their convictions and fight for them,” he said.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Child- and pet-proofing your home for the holidays
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
2026 elections will bring major changes to D.C. government
Kazakh Senate approves anti-LGBTQ propaganda bill
-
Politics5 days agoLGBTQ Democrats say they’re ready to fight to win in 2026
-
District of Columbia4 days ago
Brian Footer suspends campaign for Ward 1 D.C. Council seat
-
Opinions5 days ago
Lighting candles in a time of exhaustion
-
Opinions4 days ago
2026 elections will bring major changes to D.C. government
